Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure

NCT00171106 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2002
Completion date
February 29, 2008
Enrollment
150
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, symptomatic heart failure